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Purpose: To study alterations in different retinal cell types associated with retinal ganglion cell (RGC) death after elevation
of intraocular pressure (IOP) in rats.
Methods: IOP was elevated by episcleral vein cauterization of the rat left eye. The right unoperated eye was kept as the
control. IOP was measured when rats were awake. The animals were euthanized after one week (n=4) and five weeks
(n=4). Their eyes were enucleated, postfixed, cryoprotected, and embedded in optimal cutting temperature (OCT) medium.
Cryosections of the retina were cut at 14 µm thickness and processed for immunocytochemistry with 15 antibodies that
specifically stain different retinal cell types. The distribution and intensity of the label was analyzed by comparing sections
of control and glaucomatous retinas obtained from identical locations.
Results: The amount of amacrine cells identified by calcium binding proteins and choline acetyltransferase antibodies
decreased after five weeks of elevated IOP. By using the anti-protein kinase C-α antibody, we were able to label a
subpopulation of rod bipolar cells in control retinas but not in retinas that had elevated IOP. No changes were found in
RGCs labeled with brain derived neurotrophic factor when comparing control and glaucomatous retinas. Glial fibrillary
acidic protein and vimentin expression in glial cells increased after one week of elevated IOP.
Conclusions: After one week of elevated IOP and before the onset of RGC death, it was evident that inner retinal cells
showed remarkable changes in their molecular expression.
Glaucoma is an optic neuropathy characterized by the
elevation  of  intraocular  pressure  (IOP)  that  leads  to
degeneration of the axons and somas of the retinal ganglion
cells  (RGCs).  Clinical  studies  have  demonstrated  that  a
decrease in IOP is associated with the attenuation of retinal
damage. However, after successful treatment that lowers IOP
there is a continuation of visual field loss in some individuals
[1–3].  Studies  performed  in  rats  have  shown  that
neuroprotection of the retina is feasible with a small reduction
of IOP [4–6].
Experimental glaucoma studies have mainly focused on
RGC  damage  [7–10].  However,  the  cells  that  directly
(amacrine and bipolar cells) or indirectly (photoreceptor and
horizontal cells) come in contact with RGCs may also be
damaged. Hence, cells in the inner retina may be affected in
glaucoma as well as following ischemic damage.
Functional  electroretinographic  (ERG)  studies  have
provided clear evidence of retinal damage. In glaucomatous
retinas, ERG changes involve both the a-waves and b-waves
[11,12]. Previous studies performed in rats with episcleral
vein  cauterization  showed  that  an  increase  in  oscillatory
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potentials (OPs) appeared before any morphological changes
were  seen  in  RGCs.  OPs  are  generated  by  bipolar  and
amacrine  cells  localized  in  the  inner  nuclear  layer  (INL)
[12].  Changes  in  a-waves  and  b-waves  in  glaucomatous
retinas  returned  to  control  conditions  when  the  IOP  was
lowered  to  basal  values  [13,14].  Also,  an  increase  in  the
amplitude of the OPs was present in glaucomatous animals
[15].
Several electrophysiological studies support the notion
that the b-wave component of the ERG is generated by the
interaction between the photoreceptors and the “on” bipolar
cells. Depolarization of bipolar cells is the primary event in
the generation of the ERG b-wave [16]. A decrease in the
amplitude  of  the  b-wave  in  the  ischemic  retina  has  been
reported.  Also,  a  disturbance  of  the  retinal  calcium
homeostasis induced by high levels of excitatory amino acids
was  seen  [17–19].  The  observed  changes  may  be  a
consequence of the perturbation of the retinal connections that
we try to study at the morphological level.
The functional alterations observed in glaucoma as well
as  in  ischemic  conditions  may  reflect  biochemical  and
immunohistochemical changes. Recent studies have shown
that bipolar to amacrine cell signaling was altered in retinal
ischemia  and  reperfusion  experiments.  However,
immunohistochemical  labeling  of  the  neurons  did  not
correspond to the functional deficits seen [20,21].
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2696Following ischemia-reperfusion and optic nerve injury,
immunocytochemical altered patterns in amacrine cells were
reported in rabbit [18] and rat retina [22,23]. Similar changes
were seen in animals with elevated IOP [24]. In glaucomatous
animals, the reduction in amacrine cell number appears to be
attributable to the loss of GABAergic, cholinergic as well as
nitric oxide synthase (NOS) subpopulations. In another study,
no  significant  changes  were  detected  in  the  number  of
amacrine cells following elevation of IOP, but a loss of GABA
and glycine labeling after optic nerve transection was reported
[25]. The discrepancy observed in the results relating the
extent of damage of amacrine cells after elevation of IOP may
be due to the different methodologies used to increase IOP
and  to  evaluate  the  changes,  as  well  as  the  time  periods
studied. The main purpose of this study was to establish, by
using a variety of cell-specific markers, whether neuronal
degeneration or changes in the inner retina occurred in a rat
model of experimental glaucoma.
METHODS
Animals  and  tissue  fixation:  Eight  adult  female  Sprague-
Dawley rats bred in our university animal house (University
of the Basque Country (UPV/EHU). Rats weighing 250 g
were used throughout the study. Animals were housed in a
room with a 12 h:12 h light-dark cycle, constant temperature
(21 °C), and food and water ad libitum. At the indicated times
(1  week  and  5  weeks  of  elevated  IOP),  animals  were
anesthesized and perfused with 4% paraformaldehyde in 0.1
M phosphate buffer (PB, pH 7.4). To achieve the correct
orientation  of  the  eye  during  sectioning,  before  eye
enucleation,  we  labeled  the  dorsal  part  of  the  eye  with  a
permanent marker. We made an incision in the cornea to allow
the fixative, sucrose, and optimal cutting temperature (OCT)
medium to penetrate into the anterior chamber. Afterwards,
the whole eyes were embedded in OCT compound in liquid
nitrogen.
The eyecups were post fixed in the same fixative for 2 h
at room temperature, cryoprotected for 24 h in 30% sucrose
in 0.1 M PB at 4 °C, and embedded in OCT medium. Next,
14 µm thick cryosections were cut and stored at −20 °C until
used. All animal experiments adhered to the ARVO Statement
for the use of Animals in Ophthalmic and Vision Research.
Elevation of IOP (episcleral vein cauterization): A rise in IOP
was induced by cauterizing three episcleral veins in the left
eye, according to the method previously described [26,27].
Briefly, two dorsal episcleral veins, located near the superior
rectus muscle, and one temporal episcleral vein, situated close
to the lateral rectus muscle were isolated from the adjacent
tissues. Cauterization was performed with a low-temperature
cautery (500391, World Precision Instrument, Inc., Sarasota,
FL) precisely applied to the selected vein. Special care was
taken so that thermal damage to the neighboring tissues was
avoided. The unoperated right eyes were used as control eyes
throughout this study. Animals were divided in two groups:
group 1 contained animals whose retinas were fixed after one
week of elevated IOP, and group 2 included animals who were
euthanized after five weeks of elevated IOP. Euthanasia was
performed  by  an  intraperitoneal  injection  of  xylazine
(Rompun;  Bayer,  SA,  Barcelona,  Spain)  and  ketamine
hydrochloride (Ketolar; Parke-Davis, SL, Barcelona, Spain;
7.4 mg/ml and 31.5 mg/ml, respectively). Afterwards, the
animals were perfused with 4% paraformaldehyde in 0.1 M
phosphate buffer saline (PBS, pH 7.4). Using an applanation
tonometer  (TonoPen  XL;  Mentor,  Norwell,  MA),  we
measured IOP daily in the first group and weekly in the second
group.  This  was  done  at  the  same  time  (3  PM)  to  avoid
circadian IOP changes [27]. The results of the IOP reading
were accepted if the confidence interval was greater than or
equal to 95%. The mean values of the IOP measurements were
eventually  averaged,  and  results  were  expressed  as  mean
±SEM. Statistical significance was established by Student t-
test.
Immunohistochemistry:  Fifteen  antibodies  were  used  to
identify and define different cell types or layers of the retina
(Table 1). Retinal sections used for specific antibody labeling
were collected from the central retina, both dorsal and ventral
to the optic nerve. For the sake of consistency, photographs
were always taken (on both sides of the optic nerve head) at
half the distance between the center of the head of the optic
nerve and the periphery of the retina. In this manner, we have
analyzed antibody reactivity patterns at an identical location
of the retina in all samples. The immunocytochemical reaction
was performed simultaneously for control, one week, and five
weeks glaucomatous retinal sections for each antibody. Two
slides, containing sections from an identical localization, were
processed for each experimental group. Negative control of
the  immunohistochemistry  included  incubation  with
nonimmune serum.
Sections were incubated in a solution that contained 0.1
M Phosphate Buffer Saline (PBS; pH 7.4) and 0.25% Triton-
X 100 (Sigma-Aldrich, St. Louis, MO) two times for 10 min
at  room  temperature  to  improve  tissue  permeability.  The
retinas were incubated with primary antibody for 24 h at 4 °C.
The primary antibody was diluted in 1% BSA in PBS solution.
After incubation, sections were washed twice in PBS for 10
min each time. Then, retinas were incubated for 1 h with 1:200
goat  anti-mouse  IgG/Texas  Red  (monoclonal  antibody;
Molecular Probes, Portland, OR) or 1:200 goat anti-rabbit
IgG/Bodipy FL (polyclonal antibody; Molecular Probes). Cell
nuclei  were  stained  with  1  μg/ml  4,6-diaminodiphenyl-2-
phenylindole (DAPI; Sigma) in PBS and incubated together
with a fluorescent secondary antibody. Finally, the slides were
washed three times with PBS and mounted in 1:1 PBS and
glycerol (by volume). All preparations were observed under
an  Axioskop  2  epifluorescent  microscope  (Zeiss,  Jena,
Germany) and photographed using a Coolsnap digital camera
(RS  Photometrics,  Tucson,  AZ).  Excitation/emission
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2698wavelengths were 515/513 nm (Bodipy FL, Eugene, OR) and
595–615 nm (Texas Red, Eugene, OR).
Confocal microscopy (Olympus FV 500) was performed
to verify the presence of double-fluorescent label in bipolar
and amacrine cells. Confocal pictures obtained as stacks of
images (1 μm thickness) were analyzed with the confocal
software (Olympus, Tokyo, Japan). Image processing was
done electronically (Photoshop; Adobe Systems, Mountain
View, CA).
Quantification  of  labeled  cells:  We  have  quantified  the
labeled cells for the following markers: opsins (M, L, and S),
which  labels  the  outer  segment  (OS)  of  the  cone
photoreceptors, parvalbumin (PV), which labels AII amacrine
cells,  choline  acetyltransferase  (ChAT),  which  labels
cholinergic amacrine and ganglion cells, Protein Kinase-C-α
(PKC-α) which labels rod bipolar cells and Goα which labels
“on” bipolar cells. For each experimental group, at least ten
images at 40× were used to count the immunolabelled cells.
An unoperated contralateral retina from the same animal was
used as control. The pictures were obtained always from the
central retina, dorsal and ventral to the optic nerve head.
Immunolabeled cells were counted by following the method
used by Kielczewski et al. [25]. Briefly, three cryosections
from  each  control  and  glaucomatous  rat  eye,  were
immunostained for the different antibodies. Ten images from
each section were taken under 40× magnification. The linear
distance of each picture was measured (Axiovision 4.7; Zeiss)
and thus the number of positive cells was expressed as labeled
neurons per linear millimeters of retina. Thus, the number of
positive cells was expressed as a mean of labeled cells per mm.
For statistical analysis, the Student t-test was applied.
RESULTS
Intraocular pressure: In group 1 (one week of elevated IOP)
mean control basal IOP during the first week of this study was
18.6±0.6 mmHg (mean±SEM). IOP fluctuated between 16.8
and 20.8 mmHg. In the glaucomatous left eye a significant
increase in IOP was measured leading to a mean IOP of
30.9±0.6 mmHg. It oscillated between 29.6 and 33.0 mmHg
(statistical significance p<0.01 when compared with control
values; Figure 1A). In group 2 (five weeks of elevated IOP),
the  mean  basal  IOP  of  the  control  right  eye  was
21.5±0.6 mmHg (values between 18.9 and 22.5 mmHg) and
that of glaucomatous left eye was 29.8±1.0 mm (values ranged
between 28 and 33.6 mmHg (Statistical significance, p<0.01;
Figure 1B).
Immunohistochemistry:  Specific  antibodies  that  labeled
identifiable retinal cells were used throughout. For details, see
Table 1.
Figure  1.  Time-course  changes  in
intraocular  pressure  (IOP)  after
experimental glaucoma. Panel A shows
the changes in IOP (mmHg) in group 1
(1 week of elevated IOP). Panel B shows
the changes in IOP (mmHg) in group 2
(5 weeks of elevated IOP). Blue dots
represent control values measured in the
right  eye,  and  purple  dots  represent
experimental values measured in the left
operated  eye.  The  results  of  the  IOP
reading were accepted if the confidence
interval  was  greater  than  or  equal  to
95%.  The  mean  values  of  the  IOP
measurements  were  eventually
averaged, and results were expressed as
mean  IOP±SEM.  Five  such
measurements were made. Statistically
significant  differences  were  assessed
according to Student’s t-test. Asterisks
denote  the  level  of  significance  as
follows: *p≤0.05 and **p≤0.01.
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2699Photoreceptor  layer:  Cellular  markers  were  used  to  tag
subtypes of cells in the OS of the outer nuclear layer. The cone
outer  segment  was  identified  by  using  Middle  and  Long
wavelength cones (M/L) opsin antibody that labels middle and
long wavelength cones. The OS of the short wavelength cones
was labeled with Short wavelength cones (S opsin) antibody.
These antibodies show the same labeling patterns in control
(Figure 2A) as in the glaucomatous retinas (Figure 2B,C).
Moreover,  cone  outer  segments  were  localized  with
Differential Interference Contrast (DIC) image at a similar
location  in  the  control  (Figure  2E)  as  well  as  in  the
glaucomatous retinas (Figure 2F-G). There are no differences
in the number of the M/L and S cone OS per mm when
comparing control and both experimental groups (Figure 2H).
Horizontal and amacrine cells: No changes were found in
horizontal cells labeled with calbindin D-28 kDa antibody
either in the control or glaucomatous retina (Figure 3A-C).
Many  populations  of  amacrine  cells  were  labeled  with
calretinin antibody (Figure 3A-C) while PV antibody labeled
A-II amacrine cells (Figure 3D-F). Calretinin positive cells
were localized in the outer and inner portion of the INL, as
well as in the GCL. However, PV-positive cells were localized
in the innermost portion of the INL.
One  week  after  IOP  elevation,  calretinin  positive
amacrine  cells  showed  a  similar  pattern  compared  to  the
control retinas. However, after five weeks of elevated IOP an
appreciable decrease in the labeling, both in calretinin (Figure
3C) and PV-positive cells (Figure 3F) were observed.
Positive PV amacrine cells were counted as described
before.  No  statistical  differences  between  control  and
glaucomatous retinas, after one week of elevated IOP, were
seen. However, after five weeks of elevated IOP, we observed
a  significant  decrease  in  amacrine  cells  labeled  with  PV
(Figure 4A).
Control amacrine cells labeled with ChAT antibody were
localized in the IPL and GCL. After one and five weeks of
elevated IOP, there was a reduction in the number of marked
cholinergic amacrine and ganglion cells (Figure 3G-I and
Figure 4B,C).
Amacrine cells labeled with tyrosine hydroxylase (TH)
antibodies were scarce. No differences were found in the
Figure  2.  M/L  and  S  cone  opsin
immunohistochemical  localization.
Control (A, D, and E) and glaucomatous
retinas (B, C, F, and G) were labeled
with M/L and S cone opsin. Photographs
B and F represent retinas after 1 week of
elevated IOP and photographs C and G
show retinas after 5 weeks of elevated
IOP. Panel H represents the number of
cone  OS/mm  in  control  and
experimental groups as indicated (n=40
in  all  experimental  groups).
Abbreviations:  inner  nuclear  layer
(INL), intraocular pressure (IOP), inner
segment  (IS),  outer  nuclear  layer
(ONL),  outer  plexiform  layer  (OPL),
outer  segment  (OS),  Differential
Interference  Contrast  (DIC),  4,6-
diaminodiphenyl-2-phenylindole
(DAPI). Scale bar equals 20 μm.
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2700Figure 3. Calretinin, calbindin, parvalbumin, Chat, and TH inmunolocalization. Panels A-C show caretinin (green) and calbindin (red). Panels
D-F show parvalbumin (green) and DAPI (blue). Panels G-I show ChAT (green) and DAPI (blue). Panels J-L show TH (green) and DAPI
(blue). Pictures A-J represent control retinas, pictures B, E, H, and K represent glaucomatous retinas from experimental group 1 and pictures
C, F, I, and L show glaucomatous retinas from experimental group 2. Abbreviations: choline acetyltransferase (ChAT), ganglion cell layer
(GCL), inner nuclear layer (INL), intraocular pressure (IOP), inner plexiform layer (IPL), outer nuclear layer (ONL), outer plexiform layer
(OPL), parvalbumin (PV), tyrosine hydroxylase (TH). Scale bar equals 20 μm.
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2701number of cells labeled after one and five weeks of elevated
IOP (Figure 3J-L).
Bipolar  cells:  Bipolar  cells  were  tagged  with  PKC-α  and
Goα antibodies. PKC-α in the control retina was present in the
outer and inner parts of the INL (Figure 5). To identify if the
cells located in the inner part of the INL were PKC-α-positive
amacrine or bipolar cells, we double labeled with PKC-α and
calretinin antibodies. Calretinin was present in amacrine cells
but did not colocalize with PKC-α bipolar cells (Figure 5A-
D). After one and five weeks of elevated IOP, there was a
reduction in the number of PKC-α immunoreactive cells in
the innermost portion of the INL (Figure 5C-D).
Figure 4. Number of cells/mm labeled
with parvalbumin and ChAT antibodies.
Panel A depicts the number of amacrine
cells, in the inner nuclear layer, labeled
with parvalbumin. Panel B shows the
number of amacrine cells, in the inner
nuclear layer, labeled with ChAT. Panel
C shows the number of ChAT positive
cells localized in the ganglion cell layer
(n=40  in  all  experimental  groups).
Statistically significant differences were
assessed according to Student’s t-test.
Asterisks  denote  the  level  of
significance  as  follows:  *p≤0.05  and
**p≤0.01.  Abbreviations:  choline
acetyltransferase (ChAT), ganglion cell
layer (GCL), inner nuclear layer (INL).
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2702Bassoon antibody marks synaptic ribbons in OPL and
conventional synapses in the IPL. Therefore, it has been used
in the present study to define the limits between the IPL and
INL, where PKC-affected cells by glaucoma were detected.
No evident synaptic changes were found between the control
and glaucomatous retinas by using bassoon (Figure 5E-H).
PKC-α is present in rod bipolar and a subpopulation of
amacrine cells, while Goα is present in both rod bipolar and
Figure 5. Confocal images of PKC-α, calretinin, bassoon, and Goα immunolocalization. Panels A-D show PKC-α (green), calretinin (red) and
DAPI (blue). Panels E-H show PKC-α (green), bassoon (red), and DAPI (blue). Panels I-Q show PKC-α (green), Goα (red), and DAPI (blue).
Arrows in B, C, F, G, and I-Q indicate a subpopulation of PKC-α-positive cells, located in the innermost INL, that may be affected by
glaucoma. Abbreviations: ganglion cell layer (GCL), inner nuclear layer (INL), intraocular pressure (IOP), inner plexiform layer (IPL), outer
nuclear layer (ONL), outer plexiform layer (OPL), protein kinase C-α (PKC-α). Scale bar equals 20 μm.
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2703“on” cone bipolar cells. Since we have found a subpopulation
of PKC-α immunoreactive cells in the innermost portion of
the INL that were affected by the increase of IOP, we double
labeled with both PKC-α and Goα antibodies to identify this
subpopulation (Figure 5I-Q).
The results show that after one week of elevated IOP,
there  was  no  significant  decrease  in  the  number  of  cells
located  in  the  innermost  portion  of  the  INL  (Figure  6A).
However,  after  five  weeks  of  elevated  IOP,  there  was  a
significant reduction in the number of cells located in the
innermost portion of the INL (Figure 6B).
Retinal  ganglion  cells:  Brain  derived  neurotrophic  factor
(BDNF) was expressed in amacrine and RGCs. There was no
apparent difference in the labeling of BDNF between the
control and glaucomatous retinas (Figure 7A-D).
Glial cells: Figure 8 shows immunolabeling of the glial cells
with  vimentin  and  glial  fibrillary  acidic  protein  (GFAP)
antibodies. Vimentin labels Müller cells processes, mainly in
the inner limiting membrane of the retina (Figure 8B). The
intensity  of  labeling  of  Müller  cells  and  their  end  feet
increased in group 1, compared to the controls (Figure 8C).
However,  the  distribution  and  intensity  of  the  vimentin
positive Müller cells, in retinas after five weeks of elevated
IOP, was similar to the control retinas (Figure 8D). Moreover,
a  disorganized  pattern  of  Müller  cells  processes  was
visualized in the last group.
GFAP labels astrocytes (Figure 8F). GFAP labeling in
group 1 (Figure 8G) was more intense than the labeling in
group 2 (Figure 8H).
DISCUSSION
Experimental  rat  glaucoma  induced  by  episcleral  vein
cauterization  produces  a  chronic  ocular  hypertension  that
leads to the progressive loss of RGCs [8]. However, early
studies performed in human, monkey, or rodent spontaneous
or  experimental  glaucoma,  have  not  detected  loss  of  any
retinal cells other than RGCs. We report here variations in the
expression  of  different  molecular  markers  that  identify
subpopulations of retinal cells, in glaucomatous retinas. Our
data reinforce the concept that although the critical pathology
of glaucoma affects mostly RGCs, the disease has a profound
impact on the whole retina.
In  this  study,  we  did  not  find  any  alterations  in
photoreceptor  opsin  expression  when  comparing  the
glaucomatous and control retinas. Similar results were found
Figure  6.  Number  of  cells  per  mm
located in the INL labeled with PKC-α
and Goα antibodies. (A) corresponds to
one week of elevated IOP, and (B) to
five weeks of elevated IOP (n=40 in all
experimental  groups).  Results  are
expressed as mean±SEM. Statistically
significant  differences  were  assessed
according to Student’s t-test. The two
asterisks  denote  the  level  of
significance,  p≤0.01.  Abbreviations:
intraocular  pressure  (IOP),  protein
kinase C-α (PKC-α).
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2704by other authors who observed no changes in rod and cones
from patients suffering primary open angle glaucoma [28] or
in animal models of experimental glaucoma [29,30]. A study
in monkeys with glaucoma found a decrease in cone opsin
mRNA levels [31]. This study had hypothesized that a reduced
choroidal  blood  flow  might  result  in  a  reduction  of
oxygenation of the photoreceptor cell layer in primates.
Horizontal cells were labeled with calbindin antibodies.
No changes in the number of immunoreactive cells were found
in glaucomatous retinas (Figure 3A-C). Similar results were
reported  in  ischemia-reperfusion  degenerative  processes
[32].
Calretinin labels AII amacrine cells in rabbits but PV
antibodies  labels  AII  amacrine  cells  in  rat  retina  [33,34].
These markers also label other non-AII amacrine in monkey,
rat,  rabbit,  and  human  retinas  [35,36].  Five  weeks  after
induced IOP elevation, we noted a decrease in the number and
intensity of calretinin-positive amacrine cells in the INL. In
ischemia-reperfusion  experiments  done  in  rat  retinas,
analogous  results  have  been  reported  regarding  calretinin
immunostaining in amacrine cells [37].
PV labels AII amacrine cells, wide-field type amacrine
cells, and displaced amacrine cells [34,38]. In the IPL, these
interneurons  are  characterized  by  lobular  appendages  in
sublamina a and narrow-field arboreal dendrites in sublamina
b. The PV expression decreased in amacrine cells five weeks
after elevation of IOP. These changes in the expression have
not  been  reported  before.  PV-amacrine  cells  showed  a
reduction  in  immunoreactivity  this  could  be  due  to  the
occurrence of a vigorous neurotransmitter release from their
lobular appendages and to a passive opening of hemi-channels
in arboreal dendrites of AII amacrine cells [39] or to a cell
death.
ChAT antibody labeled those cholinergic amacrine cells
that  use  acetylcholine  as  a  neurotransmitter.  Cholinergic
amacrine cell bodies have been found in normal rat retinas.
These cholinergic amacrine cells project their processes to
strata 2 and 4 of the IPL [40]. In the present study, we have
found fewer cholinergic amacrine cells after experimental
induction of elevated IOP. The same observations in relation
to the ChAT reduction have been described in glaucomatous
rats after two to three weeks of elevated IOP [41], DBA/2J
mouse retina [26,27] and in ischemic rat retina [22,23]. It is
known that the function of RGCs is compromised when there
is a loss of cholinergic signaling in the retina. In this sense,
the loss of cholinergic amacrine neurons [42,43] or the loss of
a  neurotransmitter  [28]  has  been  demonstrated  to  cause
changes in visual direction selectivity processing that could
also be associated with glaucoma.
The alterations reported in the present study were mainly
found in the inner retina. We observed immunohistochemical
staining changes in cells labeled with PKC-α antibody. PKC-
α is a molecular component of signal transduction pathways
regulated by calcium. PKC-α-positive cells were localized in
two rows of cells in the INL. The PKC-α-positive cells located
in the innermost row disappeared in the glaucomatous retinas
after five weeks of elevated IOP. We studied the possible
colocalization of PKC-α with specific antibodies for amacrine
cells in these cells. However, none of the markers studied
colocalized with PKC-α in the PKC-α positive cells affected
Figure  7.  Fluorescent  immunoreactivity  of  BDNF  in  control  and  glaucomatous  retinas.  Control  retinas  (A  and  B),  and  experimental
glaucomatous retinas after one week (C) and five weeks (D) of elevated IOP. Abbreviations: brain derived neurotrophic factor (BDNF),
ganglion cell layer (GCL), inner nuclear layer (INL), intraocular pressure (IOP), inner plexiform layer (IPL), outer nuclear layer (ONL), outer
plexiform layer (OPL). Scale bar equals 20 μm.
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2705in glaucoma (data not shown). Therefore, we can not conclude
that the cells were amacrine.
PKC-α  antibody  labels  rod  bipolar  cells  and
dopaminergic amacrine cells in rat retinas [36,44]. However,
we  did  not  observe  any  decrease  in  the  number  of
dopaminergic amacrine cells. Thus, we believe that some
PKC-α-positive cells present in the control retinas did not
express PKC-α or disappear in glaucomatous retinas.
To identify if the affected group of TH labeled cells that
decreased  in  number  in  the  glaucomatous  retinas  were
amacrine cells, we did a double labeling with Goα. We found
that the number of PKC-α-positive and Goα-negative cells
decreased  after  five  weeks  of  elevated  IOP  (Figure  6B),
confirming that the type of affected cells could be either a
subtype  of  amacrine  positive  for  PKC-α  but  negative  for
calretinin, ChAT, or PV or a subtype of PKC-α bipolar cell.
AII  amacrine  cells  represent  the  major  output  of  rod
bipolar  cells.  Signaling  from  rod  and  cone  pathways
converges in the inner retina, specifically in AII amacrine
cells. In mammalian retinas, rod signal passes into the cone
pathways by means of gap junctions established between AII
amacrine cells and “on” cone bipolar cells [45].
We cannot confirm if the PKC-α rod bipolar cells that
disappeared in glaucomatous retinas have died or are not
Figure 8. Fluorescent immunoreactivity of vimentin and GFAP in control and glaucomatous retinas. Panels A-D depict vimentin (red) antibody
expression in control (A-B) and glaucomatous retinas after one week (C), and five weeks (D) of elevated IOP. Panels E-H indicate GFAP
(green) antibody expression in astrocytes in control (E-F), one week (G), and five weeks of elevated IOP (H). Nuclei of the cells were marked
with DAPI (blue). Abbreviations: ganglion cell layer (GCL), green fibrillary acidic protein (GFAP), inner nuclear layer (INL), intraocular
pressure (IOP), inner plexiform layer (IPL), outer nuclear layer (ONL), outer plexiform layer (OPL). Scale bar represents 20 μm.
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2706expressing  these  molecular  markers.  Nonetheless,  this
alteration may be related to the changes noticed in ERG from
glaucomatous rats [13]. It is assumed that OPs are generated
by bipolar cells that make contact with amacrine cells and the
dendrites of RGCs [46]. Our results suggest that glaucoma
induces an extensive alteration in a subtype of amacrine cells
and  in  rod  and  cone  “on”  bipolar  cells  that  may  become
hypersensitive to the inputs from amacrine cells.
It is worth pointing out that not only were the amacrine
cells affected by RGCs degeneration, but also the second order
presynaptic  bipolar  neurons  were  affected.  Interestingly,
amacrine  and  bipolar  cell  damage  has  also  been  seen  in
animals with retinitis pigmentosa (P23H, RCS rats) [37,47]
and Leber congenital amaurosis (RPE65 canine retina) [48].
However,  in  these  diseases,  cell  damage  initiates  in  the
opposite part of the retina, starting with the photoreceptor cell
layer and projecting toward the INL cells.
The  distribution  of  BDNF-positive  cells  was  not
apparently affected. Although we did not count the number of
cells in this study, we have previously demonstrated that after
experimental glaucoma, RGCs die by apoptosis [5,8] and that
all  RGCs  are  positive  to  BDNF  [49,50],  thus  we  cannot
disregard the observation that the elevation of IOP reduced
the number of BDNF positive cells.
Glial cells have been shown to play an important role in
the metabolism of neurotransmitters. In addition, they serve
as modulators of synaptic transmission and help to maintain
a  homeostatic  environment  for  neurons  [51].  It  is  well
documented that under normal conditions Müller cells do not
express GFAP [52], being only present in astrocytes, while
vimentin is the natural cytoskeleton component present in
Müller cells. Different types of damage, including glaucoma,
induce the expression of GFAP in Müller cells [41,53–55].
Our results confirm these observations. GFAP and vimentin
immunoreactivity  was  markedly  increased  in  Müller  cells
after one week of elevated IOP. Furthermore, after five weeks
of  elevated  IOP,  vimentin  immunoreactivity  showed  a
disorganized pattern of Müller cell extensions, similar to what
we [50] and others [56] have found after acute ischemia.
Based on our results, we consider important to further
investigate if a subpopulation of RGCs dies soon after IOP
elevation.  Also,  the  relationship  of  these  RGCs  with  the
circuitry of the rod and “on” cone pathways would be worth
analyzing.
The  changes  observed  in  the  distribution  of  the
immunoreactivity  in  the  hypertensive  rat  retina  are  more
severe in the inner retina than in the outer retina, and especially
affect the AII amacrine and bipolar cells. To our knowledge,
we have described for the first time that the bipolar cells
pathway is also damaged in the hypertensive eye, given the
changes observed with the PKC-α and Goα antibodies. The
alterations  in  bipolar  cells  are  not  surprising  when  one
considers that RGCs lose their presynaptic connections. The
changes noticed may represent a plasticity mechanism or a
neuronal  reprogramming  in  the  circuitry  [57].  The
degeneration of the retina is a dynamic process where a loss
of afferents induces changes in the connectivity and in the
molecular expression of their cells.
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